The deubiquitinase USP11 promotes ovarian cancer chemoresistance by stabilizing BIP

Xiaolin Zhu; Yiping Zhang; Qingyu Luo; Xiaowei Wu; Furong Huang; Tong Shu; Yong Wan; Hongyan Chen; Zhihua Liu

doi:10.1038/s41392-021-00580-w

The deubiquitinase USP11 promotes ovarian cancer chemoresistance by stabilizing BIP

Xiaolin Zhu, Yiping Zhang, Qingyu Luo, Xiaowei Wu, Furong Huang, Tong Shu, Yong Wan, Hongyan Chen^*, Zhihua Liu^*

^*Corresponding author for this work

Obstetrics and Gynecology

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Original language	English (US)
Article number	264
Journal	Signal Transduction and Targeted Therapy
Volume	6
Issue number	1
DOIs	https://doi.org/10.1038/s41392-021-00580-w
State	Published - Dec 2021

ASJC Scopus subject areas

Genetics
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41392-021-00580-w

Cite this

@article{f8f9aacd2d4c43cd9bbc1b7b48a20b60,

title = "The deubiquitinase USP11 promotes ovarian cancer chemoresistance by stabilizing BIP",

author = "Xiaolin Zhu and Yiping Zhang and Qingyu Luo and Xiaowei Wu and Furong Huang and Tong Shu and Yong Wan and Hongyan Chen and Zhihua Liu",

note = "Funding Information: This study was supported by funding from the National Key R&D Program of China (2020YFA0803300), the National Natural Science Foundation of China (82030089), the CAMS Innovation Fund for Medical Sciences (2016-I2M-1-001, 2019-I2M-1-003, 2019-I2M-2-004), and the Non-profit Central Research Institute Fund of CAMS (2019PT310027).",

year = "2021",

month = dec,

doi = "10.1038/s41392-021-00580-w",

language = "English (US)",

volume = "6",

journal = "Signal Transduction and Targeted Therapy",

issn = "2095-9907",

publisher = "Springer Nature",

number = "1",

}

TY - JOUR

T1 - The deubiquitinase USP11 promotes ovarian cancer chemoresistance by stabilizing BIP

AU - Zhu, Xiaolin

AU - Zhang, Yiping

AU - Luo, Qingyu

AU - Wu, Xiaowei

AU - Huang, Furong

AU - Shu, Tong

AU - Wan, Yong

AU - Chen, Hongyan

AU - Liu, Zhihua

N1 - Funding Information: This study was supported by funding from the National Key R&D Program of China (2020YFA0803300), the National Natural Science Foundation of China (82030089), the CAMS Innovation Fund for Medical Sciences (2016-I2M-1-001, 2019-I2M-1-003, 2019-I2M-2-004), and the Non-profit Central Research Institute Fund of CAMS (2019PT310027).

PY - 2021/12

Y1 - 2021/12

UR - http://www.scopus.com/inward/record.url?scp=85110026417&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85110026417&partnerID=8YFLogxK

U2 - 10.1038/s41392-021-00580-w

DO - 10.1038/s41392-021-00580-w

M3 - Letter

C2 - 34257276

AN - SCOPUS:85110026417

SN - 2095-9907

VL - 6

JO - Signal Transduction and Targeted Therapy

JF - Signal Transduction and Targeted Therapy

IS - 1

M1 - 264

ER -

The deubiquitinase USP11 promotes ovarian cancer chemoresistance by stabilizing BIP

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this